Physician profile
Donald E Adams
NPI 1881665347
$5,695.05
in general payments reported to CMS, 2019-2025
38 companies · $3,057 in 2025
The $3,057 reported for 2025 was more than what 96% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $924 · 2020: $472 · 2021: $333 · 2022: $179 · 2023: $244 · 2024: $487 · 2025: $3,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,080 · Travel and Lodging: $1,683 · Gift: $23.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,080.43 |
| Travel and Lodging | $1,683.30 |
| Gift | $23.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinefrontier, INC. | $2,526.26 | 2024-2025 | Nanofuse, Sijfuse, Inspan |
| Abbott Laboratories | $416.38 | 2019-2025 | Proclaim, Eterna |
| Spinal Simplicity, LLC | $295.16 | 2021-2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $240.71 | 2023-2025 | Intracept, General - Pain Management |
| Daiichi Sankyo INC. | $203.80 | 2019 | |
| Nevro Corp. | $179.43 | 2019-2020 | |
| Medtronic USA, INC. | $176.30 | 2020 | |
| Curonix LLC | $168.73 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $168.06 | 2021-2023 | Intellis Adaptivestim |
| Royal Biologics, INC. | $163.20 | 2020 | |
| Collegium Pharmaceutical, INC. | $120.16 | 2019 | |
| Abbvie INC. | $117.39 | 2024-2025 | |
| Stimwave Technologies Incorporated | $100.81 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $89.77 | 2024-2025 | Dysport |
| Averitas Pharma INC. | $81.36 | 2024-2025 | Qutenza |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tonix Medicines, INC. | $67.35 | 2025 | Tonmya |
| Vertiflex, INC. | $58.30 | 2019 | |
| Biodelivery Sciences International, INC. | $42.42 | 2019-2020 | |
| Lilly USA, LLC | $35.78 | 2019-2023 | Reyvow, Emgality |
| Itf Therapeutics LLC | $32.95 | 2025 | |
| Kaleo, INC. | $32.29 | 2019 | |
| Relievant Medsystems, INC. | $32.13 | 2023 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.85 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $31.83 | 2025 | |
| Idorsia Pharmaceuticals US INC | $27.64 | 2023 | Quviviq |
| Astrazeneca Pharmaceuticals Lp | $26.37 | 2019-2020 | |
| Shionogi INC | $26.04 | 2019 | |
| Stryker Corporation | $24.85 | 2025 | Triathlon, Accolade, Trident |
| Saluda Medical Americas, INC. | $24.62 | 2024 | Evoke |
| Zyla Life Sciences, INC. | $24.57 | 2019-2020 | |
| Hydrocision, INC. | $20.65 | 2025 | Tenjet |
| Merz North America, INC. | $17.88 | 2020 | |
| Amgen INC. | $17.45 | 2019 | |
| Horizon Therapeutics Plc | $16.00 | 2019 | |
| Assertio Therapeutics, INC. | $15.98 | 2019 | |
| Sanofi Pasteur INC. | $15.26 | 2024 | |
| Pfizer INC. | $13.16 | 2019 | |
| Scilex Pharmaceuticals INC. | $12.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.